Nevertheless, inhibition of IL-6 signaling resulted in delayed PDAC progression from pancreatic intraepithelial neoplasia, and reduced primary tumor growth and recurrences in vivo [43, 44]. This evidence concerns the gene IL6 and neoplasm.